Advertisement

Picture SwedenBIO Nordic Life Science Days 2015 Stockholm 600x60px
All >

Deals > Germany

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Germany or involving German organisations.

Total search results: 6441 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 63 64 65  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Sopat–High-Tech Gründerfonds: investment, 201408 DIVESTMENT sale of shares in Sopat by HTGF to Dr Max Iann Invest GmbH 2014-08-06
i3 Membrane–DBU: grant, 201408 existent €250k to support developm of steel-based membrane technology 2014-08-01
i3 Membrane–Hamburg (govt): investment, 201408 investment by Innovationsstarter Fonds Hamburg + HTGF 2014-08-01
i3 Membrane–High-Tech Gründerfonds: investment, 201408 investment by HTGF + Innovationsstarter Fonds Hamburg 2014-08-01
Medineering–High-Tech Gründerfonds: investment, 201408 seed financing round from HTGF + Bayern Kapital + Born2Grow + consortium of business angels 2014-08-01
Medineering–SEVERAL: investment, 201408 seed financing round from HTGF + Bayern Kapital + Born2Grow + consortium of business angels 2014-08-01
IBL International–Tecan: investment, 201407 acquisition €29m in cash 2014-07-30
Artes Biotechnology–Burnet Institute: malaria vaccine, 201407– collab development funded by PATH Malaria Vaccine Initiative (MVI) 2014-07-29
Artes Biotechnology–Burnet Institute: Metavax VLP technology, 201407 license existent Artes holds international patent rights 2014-07-29
Boehringer–Zealand Pharma: peptide drug, 201407– collab + ww excl rights for cardio-metabolic disease €295m milestones + research funding + royalties 2014-07-28
Boehringer–Univ Toronto: drug target discovery, 201407– collab to characterise new drug targets in ubiquitin system 2014-07-22
InflaRx–SEVERAL: investment, 201407 financing round Series B closing of 2nd + last tranche led by bm-t Thüringen 2014-07-17
LTS Lohmann Therapie-Systeme–Hopp Group: investment, 201407– acquisition all remaining shares by existent shareholder Dievini Hopp BioTech Holding 2014-07-17
Paion–Pharmascience: investment, 201407 private placement €4m with 1.27m new shares €3.15/share to Pharmasience Intl Ltd 2014-07-17
Biosynthetic Technologies–Evonik: investment, 201407 financing round incl Evonik Venture Capital + BP Ventures 2014-07-16
Immatics–SEVERAL: investment, 201407 financing round Series D 2nd tranche €22m of €34m round Hopp + Strüngmann + Wellington Partners et al 2014-07-16
Amcure–Germany (govt): grant, 201407 BMBF subsidy via Spinnovator programme managed by Ascenion 2014-07-15
Amcure–SEVERAL: investment, 201407 financing round Series A €5m led by LBBW Venture Capital GmbH 2014-07-15
Fosun–Miacom Diagnostics: molecular diagnostics, 201407– distribution molecular mulitplex sepsis + pneumonia assays by Fosun Diagnostics in CN + Asia 2014-07-14
Ayoxxa–SEVERAL: investment, 201407 financing round Series B €9m all existing investors + new investors 2014-07-10
International Council of Biotechnology Associations–BIO Deutschland: biotechnology, 201407 BIO Deutschland is founding member of ICBA 2014-07-10
International Council of Biotechnology Associations–VCI: biotechnology, 201407 DIB is founding member of ICBA 2014-07-10
Analyticon Discovery–BRAIN: investment, 201407 acquisition of majority share €na by BRAIN w remaining shares held by management + key personnel 2014-07-03
Miacom Diagnostics–Fosun: investment, 201407 acquisition of 37% share by Shanghai Fosun Pharmaceutical Group 2014-07-02
Qiagen–Altano Diagnostics: real-time PCR test, 201412– distribution ww of RealStar Ebolavirus RT-PCR Kit 1.0 by Qiagen 2014-07-01
Qiagen–Altano Diagnostics: real-time PCR test, 2014Q3– distribution of RealStar Filovirus RT-PCR Kit by Qiagen outside US 2014-07-01
RedHill Biopharma–Wilex: upamostat, 201406– license excl ww for Mesupron outside Greater China $1m upfront + royalties of up to 30% on net revenues 2014-06-30
Medigene–SEVERAL: investment, 201406–201407 capital increase €15.9m 3m new shares + 818.7k convertible bonds 2014-06-27
Merck (DE)–Mersana: ADC technology, 201406– collab €na using Flemixer technology to develop ADCs 2014-06-24
Bayer–Dimension Therapeutics: gene therapy, 201406– collab €20m upfront + $232m milestones + royalties developm of Hemophilia A gene therapy 2014-06-23
CytoTools–Instinctif Partners: public relations, 201406 service existent by Instinctif Partners 2014-06-23
CytoTools–SEVERAL: investment, 201406 capital increase €1.7m of CytoPharma GmbH incl €0.3m from >40% owner CytoTools 2014-06-23
Definiens–SEVERAL: investment, 201406 financing round €15m led by Wellington Partners + co-led by Gilde Healthcare 2014-06-23
Paion–SEVERAL: investment, 201406–201407 capital increase €46.26m placement of 18.5m new shares €2.5/share 2014-06-18
Bruker Corp–Max Planck: mass spectrometry s/w, 201406 collab MaxQuant proteomics s/w supporting Bruker UHR-QTOF MS with MPI Matthias Mann group 2014-06-16
Merck (DE)–MorphoSys: cancer antibody drugs, 201406– strategic collab €na using Ylanthia to identify MAbs against immune checkpoints in cancer 2014-06-12
4SC–Strüngmann Group: credit, 201406–201612 loan of up to €10m w 8% interest from Santo Holding (Deutschland) GmbH 2014-06-05
Merck (DE)–Sysmex: molecular companion diagnostics, 201406– collab developm + commercialisation blood-based RAS biomarker mutation status test 2014-06-01
Luphos–AMETEK: investment, 201405 acquisition of Luphos GmbH by AMETEK 2014-05-30
Euprotec–Evotec: investment, 201405 acquisition 100% for £1.9m cash upfront + deferred business performace-based payment 2014-05-28
Neuway Pharma–SEVERAL: investment, 201405 financing round Series A €2.7m led by Wellington Partners 2014-05-25
Neuway Pharma–Wellington Partners: investment, 201405 financing round Series A totalling €2.7m led by Wellington Partners 2014-05-25
Affimed–SEVERAL: investment, 201405–201409 IPO $56m+$8.4m offering 8m+1.2m common shares $7/share at Nasdaq 2014-05-23
Biobase–Qiagen: investment, 201405 acquisition €na by Qiagen 2014-05-20
Bayer–Boston Scientific: investment, 201405–201409 acquisition $415m of interventional device business by Boston Scientific 2014-05-15
Co.don–SEVERAL: investment, 201405 capital increase €5m 2.6m new shares €1.9/share 2014-05-15
Locate Therapeutics–Heraeus: investment, 201405 undisclosed investment €na by Heraeus 2014-05-09
Affymetrix–Danaher: laboratory automation, –201405 collab product integration fully automated ViewRNA eZ Assays on Leica BOND RX staining platform 2014-05-08
Lophius–SEVERAL: investment, 201405 financing round €2m VRD GmbH + S-Refit + another existent investor 2014-05-08
Eternygen–Evotec: drug discovery services, 201405– colllab identification + developm small-molecule inhibitors agianst target in metoblic disease 2014-05-06
Bayer–Cenix BioScience: drug target discovery, 201405– supply research service €na RNAi-based techn to identify targets for undisclosed indication 2014-05-05
AllPure Technologies–Sartorius: investment, 201404– acquisition of majority stake €na by Sartorius Stedim Biotech signed 2014-04-28
CytoTools–SEVERAL: investment, 201404 capital increase €2.3m of DermaTools Biotech GmbH from mother CytoTools + existent investor 2014-04-28
Filgen–Metabolomic Discoveries: metabolomics, 201404– distribution excl of Metabolomic Discoveries’ technologies in Japan by Filgen 2014-04-25
Biobase–Murdoch Childrens Research Institute: POSSUMweb database, 201404– distribution ww excl by Biobase GmbH 2014-04-24
Boehringer–Hydra Biosciences: CNS drugs, 201404– collab ww r+d small-molecule TRPC4/5 inhibitors for CNS diseases 2014-04-24
Isarna Therapeutics–SEVERAL: investment, 201404 financing round €5.5m from existent investors incl ATNewTec + Global Asset Fonds + MIG 2014-04-24
European ScreeningPort–Fraunhofer: investment, 201406 restructuring of ESP becoming part of Fraunhofer IME 2014-04-23
Novartis–GSK: investment, 201404–201503 acquisition $5.25b upfront + $1.8b milestones + royalties of Novartis vaccine business excluding flu business 2014-04-22
High-Tech Gründerfonds–Bayer: investment, 201404 investment of Bayer Pharma AG in High-Tech Gründerfonds II 2014-04-19
Daiichi Sankyo–Max Planck: drug discovery services, 201404– supply screening services by LDC using LDC + Daiichi compound libraries 2014-04-17
4SC–EU (govt): grant, 201404– €450k grant for 4SC Discovery GmbH as part of the CV genes-at-target project 2014-04-15
Diana–Symrise: investment, 201404– planned acquisition €1.3b ANNOUNCED 2014-04-12
Qiagen–Austrian Academy of Sciences: biomarker, 201404– license excl ww to biomarker calreticulin (CALR) from CeMM Vienna 2014-04-10
Omni Life Science–ACEA Biosciences: cell analysis technology, 201404 collab OLS is excl distributor for ACEA in Austria 2014-04-09
Omni Life Science–ACEA Biosciences: cell analysis technology, 201404 collab OLS is excl distributor for ACEA in Germany 2014-04-09
Protea Biosciences–Bruker Corp: mass spectrometer, 201404 supply + installation of UltrafleXtreme MALDI TOF/TOF mass spectrometer for MS imaging 2014-04-08
Merck (DE)–Auxogyn: IVF test, 201404– license excl for commercialisation of Eeva Test in Europe + Canada to Merck Serono 2014-04-03
Debiopharm–Evotec: drug discovery services, 201404– collab + licensing discovery + developm of cancer drugs 2014-04-02
Bayer–Targenomix: plant target discovery, 201404–201903 collab 5y to discover molecular targets in plants using systems biology 2014-04-01
EcoMetals project–BRAIN: industrial biotechnology, 201404– collab BRAIN AG is industrial project partner in German-French EcoMetals research programme 2014-04-01
EcoMetals project–Germany (govt): grant, 201404– funding €4,2m from BMBF for 7 German project partners 2014-04-01
EcoMetals project–Helmholtz: industrial biotechnology, 201404– collab HZDR is lead scientific project partner in EcoMetals research programme 2014-04-01
Convergence Pharmaceuticals–Evotec: drug discovery services, 201403– collab €na pain drug r+d with Panion Ltd 2014-03-31
Univ Oulu–Bruker Corp: mass spectrometer, 201403 supply existent UltrafleXtreme MALDI Tof/Tof listed on web site of MS Core Facility 2014-03-30
Dichrom–Fortis Technologies: HPLC columns, 201403 distribution existent in Germany by Dichrom 2014-03-29
Genmab–MAB Discovery: drug discovery services, 201403– collab €na generation of antibodies for multiple Genmab targets 2014-03-27
MAB Discovery–MC Services: public relations, 201403 service existent for MAB Discovery GmbH 2014-03-27
Bionamics–Evotec: investment, 201403 acquisition €na 100% against cash + future milestone payments 2014-03-24
Evotec–Reach Separations: chromatography, 201403– collab with Reach becoming technology partner providing small molecule chromatography 2014-03-19
Seltenerden Storkwitz–BRAIN: industrial biotechnology, 201403– collab expansion strategic partnership biotech extraction of rare earth metals 2014-03-19
Activaero–Vectura: investment, 201403 acquisition €130m with €45m cash upfront + €35m in Aug 2015 + €50m in shares 2014-03-13
Inotrem–MC Services: public relations, 201403 service existent for Inotrem SA 2014-03-13
Chemie.DE–Köhl et Feling: public relations, 201403 service existent for Chemie.DE Information Service GmbH 2014-03-11
Exosome Diagnostics–Qiagen: investment, 201403 financing round Series B totalling $27m co-led by Qiagen + Arcus Ventures 2014-03-11
Glycotope–Eckert Wagniskapital: investment, 201403 financing round totalling €55m from Jossa Arznei GmbH + ELSA GmbH 2014-03-11
Glycotope–SEVERAL: investment, 201403 financing round €55m from Jossa Arznei GmbH + ELSA GmbH 2014-03-11
Glycotope–Strüngmann Group: investment, 201403 financing round totalling €55m from Jossa Arznei GmbH + ELSA GmbH 2014-03-11
4SC–Yorkville Group: credit, 201403 first tranche €500k convertible notes under up to €15m agreem from 2/14 w YA Global Master SPV Ltd 2014-03-04
Merus–Minapharm: GlymaxX technology, 201403– non-excl option + license agreem €na for use for bispecific cancer antibody from ProBioGen AG 2014-03-04
BRAIN–Germany (govt): grant, 201403– BMBF funding for collab BRAIN + Selterden Storkwitz to develop bio-mining pilot plant for rare earth metals 2014-03-01
Gerstel–Spark Holland: dried blood spot technology, 201402– supply OEM incl FTD technology + DBS Autosampler for automated DBS systems of Gerstel 2014-02-28
microDimensions–High-Tech Gründerfonds: investment, 201402 seed financing round with HTGF + Bayern Kapital + business angel Adriaan Hart de Ruijter 2014-02-27
microDimensions–SEVERAL: investment, 201402 seed financing round with HTGF + Bayern Kapital + business angel Adriaan Hart de Ruijter 2014-02-27
BRAIN–BASF: food ingredients, 201402 acquisition of anti-bitter patents + utility patents from BASF by BRAIN 2014-02-25
Sysmex–Roche: PCR technology, 201402– license ww non-excl for emPCR patent portfolio to Sysmex Inostics GmbH 2014-02-21
Proteros–MC Services: public relations, 201402 service existent for Proteros Biostructures GmbH 2014-02-20
Centogene–OMERS (CA): investment, 201402 acquisition of Centogene’s Canadian business by LifeLabs 2014-02-19
Horizon Discovery–Sirion Biotech: genomic technology, 201402– supply to + distribution of RANiONE based services + reagents by Horizon 2014-02-17
4SC–Yorkville Group: credit, 201402– up to nominally €15m convertible notes to be purchased until 12/16 by YA Global Master SPV Ltd 2014-02-12
next pagenext page 1 2 3 4 ... 63 64 65  next pagenext page



Advertisement

Picture BioM Munich Biomarker Conference 2015 München Germany December 600x60px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture BIO Deutschland European Business Development Conference 600x60px

» top

Advertisements

Picture BioM Munich Biomarker Conference 2015 München Germany December 120x180px Picture BIO Deutschland European Business Development Conference 120x240px Picture EBD Group BIO Europe 2015 BEU Munich November 120x80px Picture SwedenBIO Nordic Life Science Days 2015 Stockholm 600x60px Picture LSBC Central European Life Science Investment Conference 2015 120x240px Picture Universal Medica Innovations Days 205 Paris France October 120x180px Picture EBD Group BioPharm America 2015 BPA Boston September 120x240px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Banner [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px